A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : WHHL / Watanabe heritable hyperlipidemic

[Related PubMed/MEDLINE]
Total Number of Papers: 369
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   WHHL  (>> Co-occurring Abbreviation)
Long Form:   Watanabe heritable hyperlipidemic
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Apolipoprotein E knockout rabbit model of intracranial atherosclerotic disease. apoE-KO, ICAD, NZW
2020 Hypercholesterolemia negatively influences morphology and molecular markers of epithelial cells within the choroid plexus in rabbits. BCSFB, CP, CPECs, CSF
2020 The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (I) - Contribution to the Elucidation of the Pathophysiology of Human Hypercholesterolemia and Coronary Heart Disease. LDL
2019 In Vivo Translation of the CIRPI System: Revealing Molecular Pathology of Rabbit Aortic Atherosclerotic Plaques. CIRPI, OCT, PAT, TCFA
2019 Integral role of receptor for advanced glycation end products (RAGE) in nondiabetic atherosclerosis. AGE, RAGE, RAGE
2018 Genomic and Transcriptomic Analysis of Hypercholesterolemic Rabbits: Progress and Perspectives. LDL, VLDL
2018 Hypertension Enhances Advanced Atherosclerosis and Induces Cardiac Death in Watanabe Heritable Hyperlipidemic Rabbits. ---
2017 In vivo distribution of single chain variable fragment (scFv) against atherothrombotic oxidized LDL/beta2-glycoprotein I complexes into atherosclerotic plaques of WHHL rabbits: Implication for clinical PET imaging. APS, beta2GPI, oxLDL, scFv
2017 Inhibition of plaque progression and promotion of plaque stability by glucagon-like peptide-1 receptor agonist: Serial invivo findings from iMap-IVUS in Watanabe heritable hyperlipidemic rabbits. GLP-1, iMAP-IVUS, SMC
10  2017 Structural Remodeling of Sympathetic Innervation in Atherosclerotic Blood Vessels: Role of Atherosclerotic Disease Progression and Chronic Social Stress. NZW, SNS
11  2016 Hyperlipidemia-associated gene variations and expression patterns revealed by whole-genome and transcriptome sequencing of rabbit models. CHOL, JW, NZW
12  2016 Invivo detection of atherosclerotic plaque using non-contact and label-free near-infrared hyperspectral imaging. HSI, NIR, SVM
13  2016 Stabilization of atherosclerotic plaque by pitavastatin in Watanabe heritable hyperlipidemic rabbits: A serial tissue-characterizing intravascular ultrasound study. ---
14  2015 Compensatory UTE/T2W Imaging of Inflammatory Vascular Wall in Hyperlipidemic Rabbits. DMNC, MR, T2W, TEM, TR, UTE
15  2015 High-fructose and high-fat diet-induced insulin resistance enhances atherosclerosis in Watanabe heritable hyperlipidemic rabbits. ---
16  2015 MRI study of atherosclerotic plaque progression using ultrasmall superparamagnetic iron oxide in Watanabe heritable hyperlipidemic rabbits. HSD, MRA, SNR, USPIO
17  2015 The Arginine/ADMA Ratio Is Related to the Prevention of Atherosclerotic Plaques in Hypercholesterolemic Rabbits When Giving a Combined Therapy with Atorvastatine and Arginine. ADMA, NO, NOS
18  2014 18F-FDG PET and intravascular ultrasonography (IVUS) images compared with histology of atherosclerotic plaques: 18F-FDG accumulates in foamy macrophages. IVUS, micro-ARG
19  2014 A design strategy for small molecule-based targeted MRI contrast agents: their application for detection of atherosclerotic plaques. MRI
20  2014 Bisphenol A exposure enhances atherosclerosis in WHHL rabbits. BPA, ER, HUVECs, SMCs
21  2013 Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins. ---
22  2013 Oxytocin administration attenuates atherosclerosis and inflammation in Watanabe Heritable Hyperlipidemic rabbits. OT
23  2012 Endothelial lipase mediates HDL levels in normal and hyperlipidemic rabbits. EL, HDL, rEL
24  2012 Improved Hepatocyte Engraftment After Portal Vein Occlusion in LDL Receptor-Deficient WHHL Rabbits and Lentiviral-Mediated Phenotypic Correction In Vitro. FH, LDLR, PVE
25  2012 In vivo intravascular ultrasound-guided photoacoustic imaging of lipid in plaques using an animal model of atherosclerosis. IVPA, IVUS, RBC, RCA
26  2012 Pentosan polysulfate inhibits atherosclerosis in Watanabe heritable hyperlipidemic rabbits: differential modulation of metalloproteinase-2 and -9. MMP, PPS, TIMP, TNF-alpha
27  2011 Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits. apoA-I, IVUS, lb, LDL, sd
28  2011 HMG-CoA reductase inhibitor augments the serum total cholesterol-lowering effect of human adipose tissue-derived multilineage progenitor cells in hyperlipidemic homozygous Watanabe rabbits. FH, hADMPCs, LDL
29  2011 Roles of the WHHL rabbit in translational research on hypercholesterolemia and cardiovascular diseases. LDL
30  2011 Transplantation of human adipose tissue-derived multilineage progenitor cells reduces serum cholesterol in hyperlipidemic Watanabe rabbits. FH, hADMPCs, LDL
31  2010 Delivery of negatively charged liposomes into the atheromas of Watanabe heritable hyperlipidemic rabbits. ---
32  2010 Lipoic acid effects on established atherosclerosis. EMSA, LA, MRI
33  2010 Ultrastructural changes in atherosclerotic plaques following the instillation of airborne particulate matter into the lungs of rabbits. EHC-93
34  2010 Utility of contrast-enhanced ultrasonography for qualitative imaging of atherosclerosis in Watanabe heritable hyperlipidemic rabbits: initial experimental study. IMC, MB, ROI, TEM, US
35  2009 Hypertriglyceridemia in Watanabe heritable hyperlipidemic rabbits was associated with increased production and reduced catabolism of very-low-density lipoproteins. TG
36  2009 The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: a tribute to the late Dr. Yoshio Watanabe. ---
37  2008 Anti-atherosclerotic effect of microbial hyaluronate lyase from group B streptococci. ---
38  2008 Different role of macrophages and vascular smooth muscle cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic (WHHL) rabbit between aorta and coronary artery. Ao, CA, PCNA, VSMCs
39  2008 Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist combination on nitric oxide bioavailability and atherosclerotic change in Watanabe heritable hyperlipidemic rabbits. ACEI, ACh, NO
40  2008 Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-gamma-modulating activity, on nitric oxide bioavailability and atherosclerotic change. ACh, Ang II, PPARgamma
41  2008 Hyaluronan accumulation is elevated in cultures of low density lipoprotein receptor-deficient cells and is altered by manipulation of cell cholesterol content. ASMC, HA
42  2008 The effect of social environment on markers of vascular oxidative stress and inflammation in the Watanabe heritable hyperlipidemic rabbit. ---
43  2007 Effects of red grape skin and seed extract supplementation on atherosclerosis in Watanabe heritable hyperlipidemic rabbits. GSE
44  2007 Estrogen and phytoestrogens: Effect on eNOS expression and in vitro vasodilation in cerebral arteries in ovariectomized Watanabe heritable hyperlipidemic rabbits. BA, eNOS, LDL, PCA, SNP
45  2007 High-resolution three-dimensional aortic magnetic resonance angiography and quantitative vessel wall characterization of different atherosclerotic stages in a rabbit model. Gd, MRI
46  2007 Imaging of atherosclerosis in WHHL rabbits using high-resolution ultrasound. IMT
47  2007 Lp(a) enhances coronary atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits. Tg
48  2007 Measurement of atherosclerotic plaque volume in hyperlipidemic rabbit aorta by intravascular ultrasound. IVUS, JW
49  2007 N,N-diacetyl-L-cystine improves endothelial function in atherosclerotic Watanabe heritable hyperlipidaemic rabbits. DiNAC
50  2007 Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis. ACAT, VWA
51  2006 Antioxidants suppress plasma levels of lectinlike oxidized low-density lipoprotein receptor-ligands and reduce atherosclerosis in watanabe heritable hyperlipidemic rabbits. LDL, LOX-1, oxLDL, T-CHO
52  2006 Gradient echo MRI characterization of development of atherosclerosis in the abdominal aorta in Watanabe Heritable Hyperlipidemic rabbits. ---
53  2006 Ocular lesions in Watanabe heritable hyperlipidemic rabbits. ---
54  2006 Pactimibe stabilizes atherosclerotic plaque through macrophage acyl-CoA:cholesterol acyltransferase inhibition in WHHL rabbits. ACAT
55  2006 Pathogenesis of tendinous xanthoma: histopathological study of the extremities of Watanabe heritable hyperlipidemic rabbits. ---
56  2006 Pravastatin inhibits expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in Watanabe heritable hyperlipidemic rabbits: a new pleiotropic effect of statins. LOX-1, oxLDL, SMC
57  2006 Social experience influences hypothalamic oxytocin in the WHHL rabbit. OT, PVN
58  2006 VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits. FFA, Glc, IMCL, VEGF, VEGFs
59  2005 Characterisation of the lipoprotein structure in the St. Thomas' Mixed Hyperlipidaemic (SMHL) rabbit. apoB, FCHL, NZW, SMHL
60  2005 Diminution of angiotensin II-induced contraction of the abdominal aorta isolated from Watanabe heritable hyperlipidemic rabbits. ---
61  2005 Effect of behavioral interventions on insulin sensitivity and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. NZW
62  2005 Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits. ARB, HMG-CoA, OLM, PRV
63  2005 Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase. LPL, TC, Tg, TG
64  2005 Synthesis and structure-activity relationship of 4-substituted benzoic acids and their inhibitory effect on the biosynthesis of fatty acids and sterols. SD, TG
65  2005 Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration. CCR2, MCP-1, PPARgamma
66  2004 (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. DUR
67  2004 Alpha-tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits. ---
68  2004 Chronic treatment with fluvastatin improves smooth muscle dilatory function in genetically determined hyperlipoproteinemia. NZW
69  2004 Circulating levels of glucocorticoid hormones in WHHL and NZW rabbits: circadian cycle and response to repeated social encounter. HPA, NZW
70  2004 Correlation of vulnerable coronary plaques to sudden cardiac events. Lessons from a myocardial infarction-prone animal model (the WHHLMI rabbit). ---
71  2004 Effects of a novel antihyperlipidemic agent, S-2E, on the blood lipid abnormalities in homozygous WHHL rabbits. IDL, LDL, TC, TG, VLDL
72  2004 Effects of alpha-tocopherol and astaxanthin on LDL oxidation and atherosclerosis in WHHL rabbits. LDL
73  2004 Effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits and cholesterol-fed rabbits. ---
74  2004 Exposure to ambient particles accelerates monocyte release from bone marrow in atherosclerotic rabbits. BM, NZW
75  2004 Overexpression of lipoprotein lipase in transgenic Watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity. LPL, Tg
76  2004 Pathobiology of familial hypercholesterolemic atherosclerosis. EC, FH, LDL
77  2003 Absorption and excretion of black currant anthocyanins in humans and watanabe heritable hyperlipidemic rabbits. ---
78  2003 Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging. HASTE
79  2003 Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit). ---
80  2003 Group V and X secretory phospholipase A(2)s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions. apoAI, HDL, LDL, lysoPC, PC
81  2003 Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex. FH, LDLR
82  2003 Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia. HDL, HMG-CoA, LDL, VLDL
83  2003 Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells. NZWR
84  2003 Plaque-stabilizing effect of pitavastatin in Watanabe heritable hyperlipidemic (WHHL) rabbits. HMG-CoA, IDL, LDL, MCP, MMP, TC, VLDL
85  2002 Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits. cGK-I, EC-SOD, NO, NTG, NZWR, P-VASP
86  2002 Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits. ---
87  2002 Fluvastatin reduces modification of low-density lipoprotein in hyperlipidemic rabbit loaded with oxidative stress. HMG-CoA, LDL
88  2002 Inhibitory effect of a novel water-soluble vitamin E derivative on atherosclerosis in rabbits. LDL, TBARS, TMG
89  2002 Iron-oxide-enhanced magnetic resonance imaging of atherosclerotic plaques: postmortem analysis of accuracy, inter-observer agreement, and pitfalls. MR, ROC, USPIO
90  2002 Lipoprotein(a) enhances advanced atherosclerosis and vascular calcification in WHHL transgenic rabbits expressing human apolipoprotein(a). LDL, Tg
91  2002 New animal model for the study of postmenopausal coronary and cerebral artery function: the Watanabe heritable hyperlipidemic rabbit fed on a diet avoiding phytoestrogens. ERT
92  2002 pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque. CEA, HUA
93  2002 Social environment influences the progression of atherosclerosis in the watanabe heritable hyperlipidemic rabbit. ---
94  2002 Targeting of endothelin receptors for molecular imaging of atherosclerosis in rabbits. NZW
95  2002 Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits. ACAT, TBARS
96  2001 17beta-Estradiol but not the phytoestrogen naringenin attenuates aortic cholesterol accumulation in WHHL rabbits. ---
97  2001 Accumulation of LOX-1 ligand in plasma and atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits: identification by a novel enzyme immunoassay. LOX-1
98  2001 Development of atherosclerotic plaque with endothelial disruption in Watanabe heritable hyperlipidemic rabbit aortas. ---
99  2001 Effects of high-dose troglitaz one on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits. ---
100  2001 Foam cell formation containing lipid droplets enriched with free cholesterol by hyperlipidemic serum. ---